Establishing Management Framework for Biosafety Risk Assessments of Synthetic Biology

Abstract

Synthetic biology, an evolving interdisciplinary field encompassing revolutionary technologies, requires a comprehensive consideration of bioethics, and biosafety risks to drive scientific and technological advancements. To address these concerns, it is crucial to pay attention to synthetic biology governance, ethics principles, and legal regulations, and develop appropriate biosafety risk assessment frameworks. This study endeavors to delve into the strategies of biosafety as well as the governance of risk assessment to foster innovation in the field of synthetic biology. It provides proposals to facilitate the healthy progression of synthetic biology and enhance biosafety management infrastructure. Emphasizing the critical facets of bio-risk assessment in synthetic biology, this work particularly underscores the biosafety risks associated with various factors and methods of the biosafety risk assessment. Within this context, the assessment of biosafety risk in the implementation of synthetic biology technology requires a comprehensive evaluation. Professional technical capabilities, the accessibility of the required resources and organizational scope should be considered when it comes to the actors of synthetic biology.